Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Distributive Shock”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableEnded earlyNCT03407287
What this trial is testing

Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status

Who this might be right for
Systemic Inflammatory Response SyndromeDistributive ShockHypotension and Shock+3 more
Vanderbilt University Medical Center 180
Not applicableLooking for participantsNCT06539234
What this trial is testing

Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.

Who this might be right for
ShockVasoplegic Syndrome
University Medical Centre Maribor 80
Large-scale testing (Phase 3)Study completedNCT02338843
What this trial is testing

LJPC-501 in Patients With Catecholamine-Resistant Hypotension

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 344
Early research (Phase 1)Study completedNCT01393782
What this trial is testing

Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study

Who this might be right for
Septic Shock
George Washington University 20
Testing effectiveness (Phase 2)Study completedNCT03431077
What this trial is testing

LJPC-501 in Pediatric Patients With Hypotension

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 2
Not applicableApproved For MarketingNCT03245528
What this trial is testing

Expanded Access for LJPC-501

Who this might be right for
Catecholamine Resistant Hypotension (CRH)Distributive ShockHigh Output Shock+2 more
La Jolla Pharmaceutical Company
Testing effectiveness (Phase 2)UnknownNCT03623529
What this trial is testing

LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 100
Large-scale testing (Phase 3)Looking for participantsNCT06351150
What this trial is testing

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Who this might be right for
Vasodilatory Shock
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 214
Post-approval studies (Phase 4)Ended earlyNCT04904562
What this trial is testing

Angiotensin II for Distributive Shock

Who this might be right for
Distributive Shock
Northwestern University 2